Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: Validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N)

Supportive Care in Cancer

Volumn 16, Issue 1, 2008, Pages 47-56

  Wagner, Lynne I ^a   Beaumont, Jennifer L ^b   Ding, Beiying ^c   Malin, Jennifer ^c   Peterman, Amy ^d   Calhoun, Elizabeth ^e   Cella, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Research and Education   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Health related quality of life; Neutropenia; Older adults; Patient reported outcomes; Supportive care

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; FLU LIKE SYNDROME; FUNCTIONAL ASSESSMENT OF CANCER THERAPY NEUTROPENIA; HUMAN; LEUKOCYTE COUNT; LUNG CANCER; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZATION; RATING SCALE; RELIABILITY; SELF REPORT; VALIDITY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; FILGRASTIM; HUMANS; LEUKOCYTE COUNT; MALE; NEOPLASMS; NEUTROPENIA; NEUTROPHILS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 36949024900     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0270-7     Document Type: Article

References (20)

1. Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5:224-237
2. Balducci L, Tam J, Al-Halawani H, Shahin S, Green J, Dansey R, Ershler W (2005) A large study of the older cancer patient in the community setting: initial report of a randomized controlled trial using pegfilgrastim to reduce neutropenic complications. 2005 ASCO Annual Meeting Proceedings, Part I of II. J Clin Oncol 23(16S):8111 (June 1 Supplement)
3. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 52:69-77
4. Brucker P, Yost K, Cashy J, Webster K, Cella D (2005) General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28:192-211
5. Butt Z, Webster K, Eisenstein AR, Beaumont J, Eton D, Master GA, Cella D (2005) Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional assessment of cancer therapy-lung scale. Hematol/Oncol Clin North Am 19:389-420
6. Calhoun BA, Welshman E, Chang CH, Cella D (2001) Development and validation of a neutropenia-specific quality of life instrument (FACT-N). Blood 98:427a
7. Cattell RB (1966) The screen test for the number of factors. Multivar Behav Res 1:245-276
8. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570-579
9. Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates. Hillsdale, NJ, USA
10. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297-334
11. Fortner BV, Schwartzberg L, Tauer K, Houts AC, Hackett J, Stolshek BS (2005) Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation. Support Care Cancer 13:522-528
12. Fortner BV, Tauer KW, Okon T, Houts AC, Schwartzberg LS (2005) Experiencing neutropenia: quality of life interviews with adult cancer patients. BMC Nursing 4:4
13. Given BA, Given CW, Jeon S, Sikorskil A (2005) Effect of neutropenia on the impact of a cognitive-behavioral intervention for symptom management. Cancer 104:869-878
14. Lyman GH, Lyman CH, Agboola O, for the ANC Study Group (2005) Risk models for predicting chemotherapy-induced neutropenia. Oncologist 10:427-437
15. Ries LAG, Kosary CL, Hankey BF et al (1998). SEER Cancer Statistics Review, 1973-1995. National Cancer Institute, Bethesda, MD, USA
16. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD (1999a) Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 37(5):469-478
17. Wyrwich KW, Tierney WM, Wolinsky FD (1999b) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52(9):861-873
18. Yancik R, Ries LA (2000) Aging and cancer in America: demographic and epidemiologic perspectives. Hematol/Oncol Clin Am 14:17-23
19. Yost KJ, Eton DT (2005) Combining distribution and anchor based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof 28:172-191
20. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370